Wellington Management Group LLP Incyte Corp Transaction History

Wellington Management Group LLP

$531 Billion
Q4 2024

A detailed history of Wellington Management Group LLP transactions in Incyte Corp stock. As of the latest transaction made, Wellington Management Group LLP holds 136,362 shares of INCY stock, worth $9.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

136,362

Previous 71,730 90.1%

Holding current value

$9.57 Million

Previous $4.74 Million 98.65%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$65.08 - $83.38 $4.21 Million - $5.39 Million	64,632 Added 90.1%	136,362 $9.42 Million
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $5.91 Million - $7.07 Million	-103,098 Reduced 58.97%	71,730 $4.74 Million
Q2 2024 Aug 13, 2024	BUY	$51.18 - $63.75 $1.84 Million - $2.29 Million	35,916 Added 25.86%	174,828 $10.6 Million
Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $7.86 Million - $9.25 Million	138,912 New	138,912 $7.91 Million
Q4 2023 Feb 12, 2024	BUY	$52.16 - $64.19 $6.87 Million - $8.45 Million	131,649 New	131,649 $8.27 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $645,464 - $736,635	11,173 Added 14.45%	88,489 $5.11 Million
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $11.7 Million - $14.5 Million	-191,736 Reduced 71.26%	77,316 $4.81 Million
Q1 2023 May 12, 2023	SELL	$70.23 - $86.01 $526 Million - $644 Million	-7,488,111 Reduced 96.53%	269,052 $19.4 Million
Q4 2022 Feb 13, 2023	SELL	$67.18 - $84.11 $172 Million - $216 Million	-2,565,263 Reduced 24.85%	7,757,163 $623 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $11.1 Million - $13.9 Million	167,975 Added 1.65%	10,322,426 $688 Million
Q2 2022 Aug 15, 2022	BUY	$66.18 - $83.18 $54 Million - $67.9 Million	816,259 Added 8.74%	10,154,451 $771 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $21.8 Million - $26.3 Million	329,701 Added 3.66%	9,338,192 $742 Million
Q4 2021 Feb 11, 2022	SELL	$63.34 - $74.11 $50.5 Million - $59 Million	-796,630 Reduced 8.12%	9,008,491 $661 Million
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $127 Million - $155 Million	-1,844,756 Reduced 15.83%	9,805,121 $674 Million
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $104 Million - $114 Million	-1,299,343 Reduced 10.03%	11,649,877 $980 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $41.9 Million - $55.4 Million	-550,756 Reduced 4.08%	12,949,220 $1.05 Billion
Q4 2020 Feb 12, 2021	SELL	$80.74 - $97.7 $49.8 Million - $60.3 Million	-616,884 Reduced 4.37%	13,499,976 $1.17 Billion
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $55.4 Million - $71.5 Million	651,760 Added 4.84%	14,116,860 $1.27 Billion
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $11.7 Million - $17.2 Million	157,457 Added 1.18%	13,465,100 $1.4 Billion
Q1 2020 May 14, 2020	SELL	$63.18 - $85.97 $7.55 Million - $10.3 Million	-119,458 Reduced 0.89%	13,307,643 $975 Million
Q4 2019 Feb 11, 2020	BUY	$73.04 - $95.72 $981 Million - $1.29 Billion	13,427,101 New	13,427,101 $1.17 Billion

Others Institutions Holding INCY

# of Institutions

705

Shares Held

189M

Call Options Held

909K

Put Options Held

489K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Incyte Corp Transaction History